The utilization of the large unstained cell (LUC) parameter in lymphoid, haematopoietic and related tissue’s malignant neoplasms

Abstract

Objectives: Large unstained cells (LUCs) are a differential count parameter reported by routine hematology analysis, and LUC percentages (LUC%) reflect active lymphocytes and peroxidase-negative cells. We aimed the evaluate the LUC% parameter in routine practice towards malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic, and related tissue.

Methods: LUC analysis was performed with Siemens ADVIA® 2120 Hematology System. Data were obtained from Ankara Bilkent City Hospital’s laboratory information system.

Results: A statistical difference in the LUC % data in the case of LUC % <4.5 and LUC % ≥4.5 among preliminary diagnoses was observed (P<0.001). According to the Kruskal-Wallis test, a statistical difference was observed between preliminary diagnosis and LUC % values (P<0.001). The One-way ANOVA test with Bonferroni correction was performed for post hoc multiple comparisons of the preliminary diagnosis among LUC%. LUC% was higher in Hodgkin Lymphoma patients than Myeloid leukaemia patients (P=0.002). LUC % was higher in the Lymphoid leukaemia patients than in the patients with Hodgkin lymphoma (P<0.001), Other and unspecified types of non-Hodgkin lymphoma (P<0.001), Multiple myeloma and malignant plasma cell neoplasms (P<0.001). LUC% was higher in patients with leukemia unspecified cell type than Hodgkin lymphoma (P<0.001), Follicular lymphoma (P<0.001), Non-follicular lymphoma (P<0.001), Mature T-Cell and Natural Killer Cell lymphomas (P<0.001), Other and unspecified types of non-Hodgkin lymphoma (P<0.001), Malignant immunoproliferative diseases (P<0.001), Multiple myeloma and malignant plasma cell neoplasms (P<0.001), Lymphoid leukaemia (P<0.001), Myeloid leukaemia (P<0.001), Other leukaemias of specified cell type patients (P<0.001).

Conclusions: The present study underscores the importance of LUC% in line with ICD-10 and may provide ideas for new research. Prospective studies including patient and control groups may be useful in assessing LUC%.

Keywords

• Large unstained cells (LUCs)
• Siemens ADVIA 2120
• complete blood cell count
• ICD-10
• neoplasms

References

1. 1. Celkan TT. What does a hemogram say to us? Turk Pediatri Ars. 2020;19;55(2):103-116. doi: 10.14744/TurkPediatriArs.2019.76301.
2. 2. George-Gay B, Parker K. Understanding the complete blood count with differential. J Perianesth Nurs. 2003;18(2):96-114; quiz 115-7. doi: 10.1053/jpan.2003.50013.
3. 3. Pepedil Tanrıkulu F, Yanardağ Açık D, Özdemir M. [The Distribution of Hematological Malignancies in Geriatric Patients: A Single Center Experience]. Ankara Eğt. Arş. Hast. Derg., 2021;54(2):254-258. doi: 10.20492/aeahtd.869284. [Article in Turkish]
4. 4. Keskin M, Burcak Polat S, Ateş I, et al. Are neutrophil-to-lymphocyte ratios and large unstained cells different in hospitalized COVID-19 PCR-positive patients with and without diabetes mellitus? Eur Rev Med Pharmacol Sci. 2022;26(16):5963-5970. doi: 10.26355/eurrev_202208_29537.
5. 5. Thirup P. LUC, what is that? Clin Chem. 1999;45(7):1100. doi: 10.1093/clinchem/45.7.1100.
6. 6. Merter M, Sahin U, Uysal S, Dalva K, Yuksel MK. Role of large unstained cells in predicting successful stem cell collection in autologous stem cell transplantation. Transfus Apher Sci. 2023;62(1):103517. doi: 10.1016/j.transci.2022.103517.
7. 7. Eren F, Kösem A, Oğuz Fırat E, Neşelioğlu S, Ateş İ, Erel O. Evaluation of Large Unstained Cells (LUC) and Nitric Oxide in Diabetes Mellitus. Ankara Med J. 2022;22(4):533-541. doi: 10.5505/amj.2022.65707.
8. 8. O'Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM. Measuring diagnoses: ICD code accuracy. Health Serv Res. 2005;40(5 Pt 2):1620-1639. doi: 10.1111/j.1475-6773.2005.00444.x.

9. 9. International Statistical Classification of Diseases and Related Health Problems 10th Revision 2019 [Available from: https://icd.who.int/browse10/2019/en.
10. 10. Harris N, Kunicka J, Kratz A. The ADVIA 2120 hematology system: flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory. Lab Hematol. 2005;11(1):47-61. doi: 10.1532/LH96.04075.
11. 11. Drewinko B, Bollinger P, Brailas C, et al. Flow cytochemical patterns of white blood cells in human haematopoietic malignancies. I. Acute leukaemias. Br J Haematol. 1987;66(1):27-36. doi: 10.1111/j.1365-2141.1987.tb06886.x.
12. 12. Orazi A, Cattoretti G, Rilke F. The technicon H6000 analyzer discriminates chronic lymphocytic leukemia from other B-cell leukemias through automatic assessment of large unstained cells. Arch Pathol Lab Med. 1990;114(10):1021-1024.
13. 13. Rabizadeh E, Pickholtz I, Barak M, Isakov E, Zimra Y, Froom P. Acute leukemia detection rate by automated blood count parameters and peripheral smear review. Int J Lab Hematol. 2015;37(1):44-49. doi: 10.1111/ijlh.12225.
14. 14. Drewinko B, Bollinger P, Brailas C, Wyatt J, Simson E, Trujillo JM. Flow cytochemical patterns of white blood cells in human haematopoietic malignancies. II. Chronic leukaemias. Br J Haematol. 1987;67(2):157-165. doi: 10.1111/j.1365-2141.1987.tb02320.x.
15. 15. Lanza F, Moretti S, Latorraca A, Scapoli G, Rigolin F, Castoldi G. Flow cytochemical analysis of peripheral lymphocytes in chronic B-lymphocytic leukemia. Prognostic role of the blast count determined by the H*1 system and its correlation with morphologic features. Leuk Res. 1992;16(6-7):639-646. doi: 10.1016/0145-2126(92)90014-x.
16. 16. Drewinko B, Bollinger P, Brailas C, Wyatt J, Simson E, Trujillo JM. Flow cytochemical patterns of white blood cells in human hematopoietic malignancies: III. Miscellaneous hemopoietic diseases. Blood Cells. 1988;13(3):475-486.
17. 17. Orazi A, Milanesi B. The technicon H6000 automated hematology analyzer in the diagnosis and classification of the myelodysplastic syndromes. Haematologica. 1990;75(1):87-90.
18. 18. Bunyaratvej A, Boonkanta P, Nitiyanant P, Apibal S, Bhamarapravati N. Automated cytochemistry in non-Hodgkin's lymphoma: a new method for determination of cells from lymph node biopsy. Acta Haematol. 1986;75(4):199-202. doi: 10.1159/000206124.
19. 19. Vanker N, Ipp H. Large unstained cells: a potentially valuable parameter in the assessment of immune activation levels in HIV infection. Acta Haematol. 2014;131(4):208-212. doi: 10.1159/000355184.
20. 20. Vanker N, Ipp H. The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection. S Afr Med J. 2013;11;104(1):45-48. doi: 10.7196/samj.6983.
21. 21. Shin D, Lee MS, Kim DY, Lee MG, Kim DS. Increased large unstained cells value in varicella patients: A valuable parameter to aid rapid diagnosis of varicella infection. J Dermatol. 2015;42(8):795-799. doi: 10.1111/1346-8138.12902.
22. 22. Butthep P, Bunyaratvej A, Bhamarapravati N. Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:246-249.
23. 23. Nixon DF, Parsons AJ, Eglin RP. Routine full blood counts as indicators of acute viral infections. J Clin Pathol. 1987;40(6):673-675. doi: 10.1136/jcp.40.6.673.
24. 24. Bononi A, Lanza F, Ferrari L, et al. Predictive value of hematological and phenotypical parameters on postchemotherapy leukocyte recovery. Cytometry B Clin Cytom. 2009;76(5):328-333. doi: 10.1002/cyto.b.20476.